Fusion of Bacterial Flagellin to a Dendritic Cell-Targeting αCD40 Antibody Construct Coupled With Viral or Leukemia-Specific Antigens Enhances Dendritic Cell Maturation and Activates Peptide-Responsive T Cells.
Antibodies
/ genetics
CD40 Antigens
/ genetics
Cancer Vaccines
/ immunology
Cell Communication
Cell Line, Tumor
Cell Proliferation
Coculture Techniques
Dendritic Cells
/ drug effects
Epitopes
Filaggrin Proteins
Flagellin
/ genetics
HEK293 Cells
Humans
Lymphocyte Activation
Nuclear Proteins
/ genetics
Nucleophosmin
Proof of Concept Study
Recombinant Fusion Proteins
/ pharmacology
Signal Transduction
T-Lymphocytes
/ immunology
Toll-Like Receptor 5
/ agonists
Viral Matrix Proteins
/ genetics
acute myeloid leukemia
antibody
dendritic cell
flagellin
neoantigen
vaccine
Journal
Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960
Informations de publication
Date de publication:
2020
2020
Historique:
received:
22
09
2020
accepted:
19
10
2020
entrez:
7
12
2020
pubmed:
8
12
2020
medline:
22
6
2021
Statut:
epublish
Résumé
Conventional dendritic cell (DC) vaccine strategies, in which DCs are loaded with antigens
Identifiants
pubmed: 33281829
doi: 10.3389/fimmu.2020.602802
pmc: PMC7689061
doi:
Substances chimiques
Antibodies
0
CD40 Antigens
0
Cancer Vaccines
0
Epitopes
0
FLG protein, human
0
Filaggrin Proteins
0
NPM1 protein, human
0
Npm1 protein, mouse
0
Nuclear Proteins
0
Recombinant Fusion Proteins
0
TLR5 protein, human
0
Toll-Like Receptor 5
0
Viral Matrix Proteins
0
cytomegalovirus matrix protein 65kDa
0
Nucleophosmin
117896-08-9
Flagellin
12777-81-0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
602802Informations de copyright
Copyright © 2020 Schmitt, Tahk, Lohner, Hänel, Maiser, Hauke, Patel, Rothe, Josenhans, Leonhardt, Griffioen, Deiser, Fenn, Hopfner and Subklewe.
Références
Nat Rev Immunol. 2014 Oct;14(10):705-11
pubmed: 25190285
Proc Natl Acad Sci U S A. 2013 May 14;110(20):E1857-66
pubmed: 23630282
N Engl J Med. 2013 May 30;368(22):2059-74
pubmed: 23634996
J Exp Med. 2013 May 6;210(5):1049-63
pubmed: 23569326
Nat Commun. 2019 Nov 27;10(1):5408
pubmed: 31776331
PLoS One. 2012;7(9):e44266
pubmed: 22962607
J Immunol. 2010 Oct 15;185(8):4602-8
pubmed: 20844205
Protein Eng Des Sel. 2016 Oct;29(10):457-466
pubmed: 27578889
PLoS One. 2012;7(7):e40208
pubmed: 22808118
Science. 2015 May 15;348(6236):803-8
pubmed: 25837513
Sci Rep. 2018 Jul 26;8(1):11287
pubmed: 30050158
Proc Natl Acad Sci U S A. 2001 Sep 11;98(19):10811-6
pubmed: 11526222
Blood. 2012 Sep 6;120(10):2011-20
pubmed: 22791285
Med Res Rev. 2019 May;39(3):1053-1090
pubmed: 30450666
Nat Med. 2007 Mar;13(3):354-60
pubmed: 17334371
Nat Rev Immunol. 2007 Oct;7(10):790-802
pubmed: 17853902
Nat Rev Cancer. 2015 Aug;15(8):457-72
pubmed: 26205340
J Transl Med. 2007 Apr 12;5:18
pubmed: 17430585
Sci Rep. 2017 Jan 20;7:40878
pubmed: 28106112
Annu Rev Immunol. 2004;22:307-28
pubmed: 15032580
PLoS Pathog. 2017 Aug 21;13(8):e1006574
pubmed: 28827825
Oncoimmunology. 2013 Jan 1;2(1):e23033
pubmed: 23483678
J Immunol. 2008 Jun 15;180(12):8280-5
pubmed: 18523294
Vaccine. 2010 Dec 6;28(52):8268-74
pubmed: 20969925
Cancer Biol Ther. 2010 Nov 15;10(10):983-93
pubmed: 20855968
J Immunol. 2007 Jul 15;179(2):1147-54
pubmed: 17617608
Nature. 2017 Jul 13;547(7662):217-221
pubmed: 28678778
Blood. 2011 Dec 22;118(26):6836-44
pubmed: 21967977
Front Immunol. 2014 May 30;5:255
pubmed: 24910635
Oncotarget. 2016 Jan 19;7(3):2936-50
pubmed: 26655090
Exp Mol Med. 2017 Sep 1;49(9):e373
pubmed: 28860663
Cell Res. 2017 Jan;27(1):74-95
pubmed: 28025976
Cancer J. 2010 Jul-Aug;16(4):382-91
pubmed: 20693851
Nature. 2017 Jul 13;547(7662):222-226
pubmed: 28678784
Vaccine. 2018 Jul 5;36(29):4188-4197
pubmed: 29891347
Clin Cancer Res. 2014 May 1;20(9):2457-65
pubmed: 24634374
Cancer Cell. 2015 Jan 12;27(1):138-48
pubmed: 25500122
Vaccine. 2011 Jul 12;29(31):4897-902
pubmed: 21596084
PLoS One. 2020 Feb 6;15(2):e0227940
pubmed: 32027657
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
EBioMedicine. 2016 Jan 28;5:46-58
pubmed: 27077111
Immunotherapy. 2010 Nov;2(6):847-62
pubmed: 21091116
Immunol Lett. 2009 Aug 15;125(2):114-8
pubmed: 19555720
Proc Natl Acad Sci U S A. 2006 Aug 15;103(33):12487-92
pubmed: 16891416
Science. 2008 Apr 11;320(5873):226-30
pubmed: 18403709
J Clin Oncol. 2007 Mar 1;25(7):876-83
pubmed: 17327609
Cancer Cell. 2016 Jun 13;29(6):820-831
pubmed: 27265505
Front Immunol. 2018 Dec 13;9:2874
pubmed: 30619259
Nat Immunol. 2003 Dec;4(12):1247-53
pubmed: 14625549
Proc Natl Acad Sci U S A. 1992 May 15;89(10):4285-9
pubmed: 1350088
Vaccine. 2016 Sep 7;34(39):4712-4717
pubmed: 27516064
Vaccine. 2011 Jul 18;29(32):5145-52
pubmed: 21624416
Cancer Immunol Immunother. 2014 Oct;63(10):1061-71
pubmed: 24993563
J Clin Invest. 2019 Feb 1;129(2):774-785
pubmed: 30640174
Immunity. 2010 Oct 29;33(4):492-503
pubmed: 21029960
Vaccine. 2013 Aug 20;31(37):3879-87
pubmed: 23831323
N Engl J Med. 2005 Jan 20;352(3):254-66
pubmed: 15659725
Proc Natl Acad Sci U S A. 2016 Feb 16;113(7):E874-83
pubmed: 26831100
J Exp Med. 2004 Mar 15;199(6):775-84
pubmed: 15007094
J Exp Med. 2002 Dec 16;196(12):1627-38
pubmed: 12486105
J Clin Invest. 2011 May;121(5):1782-96
pubmed: 21540549
Blood. 2013 Apr 11;121(15):2836-44
pubmed: 23390195
Annu Rev Immunol. 2012;30:1-22
pubmed: 22136168
Curr Opin Immunol. 2005 Apr;17(2):170-4
pubmed: 15766677